Atrion (NASDAQ:ATRI) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Atrion (NASDAQ:ATRI) in a research report report published on Tuesday. The firm issued a sell rating on the medical instruments supplier’s stock.

Atrion Price Performance

Shares of ATRI stock opened at $459.92 on Tuesday. Atrion has a 12 month low of $274.98 and a 12 month high of $503.24. The firm has a market cap of $809.46 million, a PE ratio of 43.23 and a beta of 0.69. The stock has a 50 day moving average of $457.78 and a 200-day moving average of $438.27.

Atrion (NASDAQ:ATRI) last released its earnings results on Thursday, August 8th. The medical instruments supplier reported $0.23 EPS for the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%. The firm had revenue of $48.77 million during the quarter.

Institutional Investors Weigh In On Atrion

A number of institutional investors have recently added to or reduced their stakes in ATRI. Quadrant Capital Group LLC acquired a new position in Atrion in the 4th quarter valued at approximately $36,000. Headlands Technologies LLC bought a new stake in shares of Atrion during the second quarter valued at approximately $54,000. Benjamin F. Edwards & Company Inc. acquired a new position in shares of Atrion in the second quarter valued at $72,000. EntryPoint Capital LLC bought a new position in Atrion in the first quarter worth $91,000. Finally, Comerica Bank boosted its stake in Atrion by 60.9% during the first quarter. Comerica Bank now owns 415 shares of the medical instruments supplier’s stock worth $192,000 after buying an additional 157 shares in the last quarter. 66.19% of the stock is owned by institutional investors and hedge funds.

About Atrion

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.